Libo Yin

498 total citations
16 papers, 395 citations indexed

About

Libo Yin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Libo Yin has authored 16 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Libo Yin's work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (6 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). Libo Yin is often cited by papers focused on MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (6 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). Libo Yin collaborates with scholars based in Germany and China. Libo Yin's co-authors include Ingrid Herr, Wolfgang Groß, Jury Gladkich, Xi Xiao, Carsten Sticht, Yuhua Zhu, Yu Chen, Jiangang Yang, Jianyin Zhou and Norbert Gretz and has published in prestigious journals such as International Journal of Cancer, Cancer Letters and Oncotarget.

In The Last Decade

Libo Yin

16 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Libo Yin Germany 12 250 176 67 61 49 16 395
Melanie Rothley Germany 13 342 1.4× 156 0.9× 43 0.6× 126 2.1× 14 0.3× 20 618
Qingsong Guo China 12 238 1.0× 113 0.6× 136 2.0× 134 2.2× 21 0.4× 26 490
Kamal Shaik Fakiruddin Malaysia 10 240 1.0× 105 0.6× 37 0.6× 172 2.8× 85 1.7× 14 429
Lexiang Zeng China 10 246 1.0× 166 0.9× 59 0.9× 57 0.9× 16 0.3× 19 440
Yolla Haibe Lebanon 8 196 0.8× 106 0.6× 31 0.5× 155 2.5× 15 0.3× 15 404
Zumin Xu China 13 294 1.2× 141 0.8× 19 0.3× 109 1.8× 22 0.4× 24 427
Yanping Zhong China 14 161 0.6× 83 0.5× 87 1.3× 172 2.8× 16 0.3× 37 476
Fuxiang Yu China 12 196 0.8× 121 0.7× 101 1.5× 81 1.3× 72 1.5× 27 460

Countries citing papers authored by Libo Yin

Since Specialization
Citations

This map shows the geographic impact of Libo Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Yin more than expected).

Fields of papers citing papers by Libo Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libo Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Yin. The network helps show where Libo Yin may publish in the future.

Co-authorship network of co-authors of Libo Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Libo Yin. A scholar is included among the top collaborators of Libo Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libo Yin. Libo Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Cao, Yi, et al.. (2024). Network Pharmacology, Molecular Docking Analysis and Experiment Validations on Molecular Targets and Mechanisms of the Dispel-Scar Ointment in Scar Treatment. Combinatorial Chemistry & High Throughput Screening. 28(13). 2318–2338. 1 indexed citations
2.
3.
Yan, Bin, Li Liu, Libo Yin, et al.. (2021). Sulforaphane Inhibits the Expression of Long Noncoding RNA H19 and Its Target APOBEC3G and Thereby Pancreatic Cancer Progression. Cancers. 13(4). 827–827. 20 indexed citations
4.
Xiao, Xi, Carsten Sticht, Libo Yin, et al.. (2020). Novel plant microRNAs from broccoletti sprouts do not show cross-kingdom regulation of pancreatic cancer. Oncotarget. 11(14). 1203–1217. 10 indexed citations
5.
Buglioni, Laura, Libo Yin, Wolfgang Groß, et al.. (2020). Novel Broccoli Sulforaphane-Based Analogues Inhibit the Progression of Pancreatic Cancer without Side Effects. Biomolecules. 10(5). 769–769. 18 indexed citations
6.
Yin, Libo, et al.. (2019). Downregulation of PHF6 Inhibits Cell Proliferation and Migration in Hepatocellular Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 34(4). 245–251. 10 indexed citations
7.
Yin, Libo, Xi Xiao, Li Liu, et al.. (2019). MicroRNA-365a-3p inhibits c-Rel-mediated NF-κB signaling and the progression of pancreatic cancer. Cancer Letters. 452. 203–212. 34 indexed citations
8.
Yin, Libo, Xi Xiao, Li Liu, et al.. (2019). Sulforaphane Induces miR135b-5p and Its Target Gene, RASAL2, thereby Inhibiting the Progression of Pancreatic Cancer. Molecular Therapy — Oncolytics. 14. 74–81. 39 indexed citations
9.
Yin, Libo, Jury Gladkich, Xi Xiao, et al.. (2019). Inhibition of miR30a-3p by sulforaphane enhances gap junction intercellular communication in pancreatic cancer. Cancer Letters. 469. 238–245. 36 indexed citations
10.
Mayer, Philipp, Frank Bergmann, Esther Herpel, et al.. (2019). Interleukin 21 Receptor/Ligand Interaction Is Linked to Disease Progression in Pancreatic Cancer. Cells. 8(9). 1104–1104. 16 indexed citations
11.
Liu, Li, Zhefu Zhao, Libo Yin, et al.. (2018). Simvastatin inhibits sonic hedgehog signaling and stemness features of pancreatic cancer. Cancer Letters. 426. 14–24. 33 indexed citations
12.
Herr, Ingrid, Zhefu Zhao, Libo Yin, et al.. (2017). MiR-127 and miR-376a act as tumor suppressors by in vivo targeting of COA1 and PDIA6 in giant cell tumor of bone. Cancer Letters. 409. 49–55. 32 indexed citations
13.
Zhao, Zhefu, Nathalie Bauer, Ewa Aleksandrowicz, et al.. (2017). Intraductal papillary mucinous neoplasm of the pancreas rapidly xenografts in chicken eggs and predicts aggressiveness. International Journal of Cancer. 142(7). 1440–1452. 20 indexed citations
14.
15.
Yin, Libo, et al.. (2014). Adipose tissue-derived mesenchymal stem cells differentiated into hepatocyte-like cells in vivo and in vitro. Molecular Medicine Reports. 11(3). 1722–1732. 69 indexed citations
16.
Lin, Guimei, Zhili Xu, Hui Gao, et al.. (2011). Epoxyaurapten inhibition of smooth muscle contraction and phosphorylation of myosin light chain by myosin light chain kinase. Journal of Medicinal Plants Research. 5(15). 3412–3420. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melanie Rothley Breakdown of academic impact, for papers by Qingsong Guo Breakdown of academic impact, for papers by Kamal Shaik Fakiruddin Breakdown of academic impact, for papers by Lexiang Zeng Breakdown of academic impact, for papers by Yolla Haibe Breakdown of academic impact, for papers by Zumin Xu Breakdown of academic impact, for papers by Yanping Zhong Breakdown of academic impact, for papers by Fuxiang Yu
Rankless by CCL
2026